A phase 1 expansion cohort of the fibroblast growth factor receptor (FGFR) inhibitor AZD4547 in patients (pts) with advanced gastric (GC) and gastroesophageal (GOJ) cancer.
2014 ◽
Vol 32
(15_suppl)
◽
pp. 2620-2620
◽
2014 ◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 2501-2501
◽
2015 ◽
Vol 33
(15_suppl)
◽
pp. 2545-2545
◽